BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11654902)

  • 1. CMA guidelines on MD-drug industry relations part of international trend.
    Williams JR
    CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
    [No Abstract]   [Full Text] [Related]  

  • 2. The CMA's MD-drug industry guidelines offer advice, nothing more.
    Woollard R
    CMAJ; 1991 Dec; 145(11):1498-9. PubMed ID: 11649304
    [No Abstract]   [Full Text] [Related]  

  • 3. CMA guidelines concerning relationship of MDs and drug industry to be revised, board told.
    Sullivan P
    CMAJ; 1993 Jan; 148(2):273-5. PubMed ID: 11652162
    [No Abstract]   [Full Text] [Related]  

  • 4. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
    Williams JR
    CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines on gifts to physicians from industry: an update.
    American Medical Association. Council on Ethical and Judicial Affairs
    Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
    Rapp MS; Woollard R
    CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
    [No Abstract]   [Full Text] [Related]  

  • 7. Physicians and the pharmaceutical industry.
    Canadian Medical Association
    CMAJ; 1992 Feb; 146(3):388A-C. PubMed ID: 11654903
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for relationships between industry and the American College of Obstetricians and Gynecologists and its fellows. ACOG Committee Opinion No. 45.
    American College of Obstetricians and Gynecologists [ACOG]. Committee on Ethics
    ACOG Comm Opin; 1985 Oct; No. 45():1 p. PubMed ID: 11660326
    [No Abstract]   [Full Text] [Related]  

  • 9. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
    Maatz CT
    High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
    Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
    Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for interactions with pharmaceutical companies.
    American Medical Association. Resident Physicians Section
    JAMA; 1993 Sep; 270(10):1250. PubMed ID: 11643149
    [No Abstract]   [Full Text] [Related]  

  • 12. AMA's gift guidelines.
    Conley RB
    Food Drug Cosmet Med Device Law Dig; 1993; 10():19-27. PubMed ID: 11654936
    [No Abstract]   [Full Text] [Related]  

  • 13. What market values are doing to medicine.
    Relman AS
    Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349
    [No Abstract]   [Full Text] [Related]  

  • 14. Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
    Zoorob R; Larzelere M
    J La State Med Soc; 2004; 156(1):28-32. PubMed ID: 15000210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
    Studdert DM; Mello MM; Brennan TA
    N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
    [No Abstract]   [Full Text] [Related]  

  • 16. Student rally. Med school attendees write ethics code on drug firms.
    Romano M
    Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychiatry has dangerous alliance with drug companies.
    Mosher LR
    Behav Healthc Tomorrow; 1999 Jun; 8(3):6. PubMed ID: 11645352
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research.
    Woo SL
    Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736
    [No Abstract]   [Full Text] [Related]  

  • 19. Code of ethics; issues in ethics.
    American Speech-Language-Hearing Association
    ASHA; 1992 Mar; 34(3 Suppl. 9):1-21. PubMed ID: 11652233
    [No Abstract]   [Full Text] [Related]  

  • 20. Advancing professional ethics in epidemiology.
    Coughlin SS
    J Epidemiol Biostat; 1996; 1(2):71-7. PubMed ID: 11655318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.